Estimated Liability for New York Opioid Stewardship Act

No definition available.

Name:	cah_EstimatedLiabilityForNewYorkOpioidStewardshipAct
Namespace Prefix:	cah_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.

+ References

No definition available.

+ Details

Name:	cah_ProjectCostsOnInvestmentAndOtherSpending
Namespace Prefix:	cah_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Write-down of assets held for sale

+ References

No definition available.

+ Details

Name:	cah_WriteDownOfAssetsHeldForSale
Namespace Prefix:	cah_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349

+ Details

Name:	us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

Name:	us-gaap_InventoryRecallExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599

+ Details

Name:	us-gaap_NumberOfOperatingSegments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

+ References

+ Details

Name:	us-gaap_NumberOfReportableSegments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	cah_CordisDivestitureAxis=cah_CordisDivestitureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=cah_NewYorkOpioidStewardshipActMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	cah_SterileSurgicalGownRecallAxis=cah_SterileSurgicalGownRecallMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Segment Information (Narrative) (Details) $ in Millions	3 Months Ended		9 Months Ended
Segment Information (Narrative) (Details) $ in Millions	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Mar. 31, 2021 USD ($) segment	Mar. 31, 2020 USD ($)
Segment Reporting Information [Line Items]
Gain (Loss) Related to Litigation Settlement	$ 15	$ 35	$ 1,085	$ 5,729
Project costs on investment and other spending	4	17	$ 15	37
Number of reportable segments \| segment			2
Number of operating segments \| segment			2
Number of operating segments \| segment			2
Number of reportable segments \| segment			2
Project costs on investment and other spending	4	$ 17	$ 15	37
Cordis Divestiture
Segment Reporting Information [Line Items]
Write-down of assets held for sale	$ 58		58
New York Opioid Stewardship Act [Member]
Segment Reporting Information [Line Items]
Estimated Liability for New York Opioid Stewardship Act			41
Total Opioid Litigation [Member]
Segment Reporting Information [Line Items]
Gain (Loss) Related to Litigation Settlement			$ 1,020	5,630
Sterile Surgical Gown Recall [Member]
Segment Reporting Information [Line Items]
Inventory Recall Expense				$ 95